Tera Science filed a correction to its major shareholder report on the capital increase decision originally submitted on November 7, 2024, on July 2, 2026.
The correction pertains solely to schedule changes: the payment date moves from July 2, 2026 to July 30, 2026, the listing date from July 28, 2026 to August 20, 2026, and the subscription date from July 2, 2026 to July 30, 2026.
All key terms of the third-party allotment remain unchanged: issuance of 25 million shares at 100 won each, raising 2.5 billion won for operating funds, and a change of control to Seojin Panji Co., Ltd.
The company has been suspended from trading since March 20, 2024, and faces delisting risk with a 23.5% dilution ratio from the capital increase.
[AI Summary]This correction is a routine scheduling adjustment with no immediate impact on shareholder value, but the underlying risks of trading suspension, potential delisting, and severe dilution from the deeply discounted issuance persist.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)